Wada, Fumiya
Nishikori, Momoko http://orcid.org/0000-0003-4171-2162
Hishizawa, Masakatsu
Watanabe, Mitsumasa
Aiba, Akiko
Kitano, Toshiyuki
Shimazu, Yayoi
Shindo, Takero
Kondo, Tadakazu
Takaori-Kondo, Akifumi
Article History
Received: 5 August 2020
Revised: 1 September 2020
Accepted: 13 September 2020
First Online: 26 September 2020
Compliance with ethical standards
:
: M. Nishikori has received honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical. A. Takaori-Kondo has received honoraria from Bristol Myers Squibb, Celgene, Novartis, MSD, Kyowa Kirin, Astellas, and funding from Bristol Myers Squibb, Celgene, COGNANO, Ono, and Thyas, and has received research support from Astellas, Chugai, Eisai, Kim’s Korean Ginseng, Kyowa Kirin, Nippon Shinyaku, Ohara, Ono, Otsuka, Pfizer, Popuri, Takeda, and Sanofi. All other authors do not have any conflict of interest to declare.